Announcements
Sidley Advises PhaseV in Its US$50 Million Series A Financing
May 14, 2025
Sidley advised PhaseV Trials Inc., a leader in AI/ML-driven clinical development, in its US$50 million Series A financing round. The round was co-led by Accel and Insight Partners, with participation from Viola Ventures, Exor Ventures, and LionBird.
For additional information, please refer to the press release.
The Sidley team was led by Dr. Idan Netser and Jake Funk (Emerging Companies and Venture Capital).
Contacts
Capabilities
Suggested News & Insights
2026 Emerging Companies & Venture Capital SummitWednesday, May 20, 2026Sidley Represents Neomorph in Its US$100 Million Series B FinancingApril 15, 2026SEC Releases Landmark Interpretation on Application of U.S. Securities Laws to Crypto Assets, in Coordination With CFTCMarch 24, 2026Sidley Represents Crossbow Therapeutics in US$77 Million Series B FinancingMarch 18, 2026Sidley Adds Corporate and Securities Partner Steven Przesmicki in San DiegoMarch 10, 2026New York LLC Transparency Act Took Effect January 1, 2026; U.S.-Formed LLCs Exempt from Reporting ObligationsFebruary 25, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory